Business Operations Best Practices
Best Practices, LLC has conducted extensive research in the field of Business Operations. Browse through and sample our published Business Operations research in the topics below:
| |  | Merger & Acquisition Integration Excellence
Create superior business growth and value for stakeholders by mastering the five key areas of integration: Business Development; Integration Planning; Culture & Personnel Management; Sales, Marketing & Customer Service; Technology & Systems. Conducted on behalf of 11 corporations from seven economic sectors, this study identifies the effective and innovative practices that top companies use to create superior growth and value for stakeholders through integration excellence. Distilled from hundreds of resources and drawn from more than 50 high-performing companies, the study clearly delineates the practices that ensure success in the five key integration areas.
Best Practices in Supply Base Management
Making improvements in supplier selection and relationship management can be an advantage in today's competitive marketplace. Such improvements result in better products, reduced costs, stronger supplier partnerships and more efficient business processes.
This Best Practices Benchmarking® Report profiles various practices from more than 100 best-in-class companies. These organizations are leading the way in vendor selection, material selection, movement technology selection and implementation, and vendor relationship management and performance.
Quantitative and qualitative data in this report include: delivery and quality performance, reduction of complaints, reduction of suppliers, decrease in material rejections and percentage of cost savings.
Best Practices in Utilizing Health Outcomes Data
Optimizing the use of Health Outcomes data is vital to the success of biotechnology and pharmaceutical companies. This report provides insight and best practices that are being used by companies and reviews the use of Health Outcomes data in promotional/commercial settings and the possible Regulatory issues that arise as a result of their use.
This report identifies how companies continue to navigate using prospective and retrospective Health Outcomes data in on-label and off-label instances. It gives insight into how companies are actively utilizing data that is critical to the success of drugs and achieving beneficial formulary status.
|
|